3American Thoracic Society Guidelines for the management of adults with community acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med, 2001, 163:1730-1754.
4Tan JS. Nonresponses and treatment failures with conventional empiric regimens in patients with community acquired pneumonia. Infect Dis Clin North Am, 2004, 18:883-897.
5Zalacain R, Torres A, Celis R, et al. Community-acquired pneumonia in the elderly: spanish multicentre study. Eur Respir J,2003,21:294-302.
6Woodhead M, Blasi F, Ewig S, et al. Guidlines for the management of adult lower respiratory tract infections. Eur Respir J, 2005,26 : 1138-1180.
7Moola S, Hagbergl L,Churchyard GA, et al. A muhicenter study of grepafloxacin and clarithromycin in the treatment of patients with community acquired pneumonia. Chest, 1999, 116:974-983.
8Ewig S, Ruiz M, Torres A, et al. Pneumonia acquired in the community through drug-resistant Streptococcus pneumonia. Am J Respir Crit Care Med, 1999,159 : 1835-1842.
9Niederman MS, Mandll LA, Anzueto A, et al. Guidelines for the management of adult with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med,2001,163 : 1730-1754.
10Sato T, Aoshima M, Ohmagari N, et al. Usefulness of sputum Gram staining in community acquired pneumonia. Nihon Kokyuki Gakkai Zasshi, 2002,40:558-563.
